Literature DB >> 32067415

Horyzons USA: A moderated online social intervention for first episode psychosis.

Kelsey A Ludwig1, Julia W Browne1,2, Arun Nagendra1, John F Gleeson3,4, Simon D'Alfonso4, David L Penn1,3, Mario Alvarez-Jimenez4,5.   

Abstract

AIM: We evaluated the feasibility and acceptability of Horyzons, an online social media platform designed to facilitate relationship development among, and introduce therapeutic content to, first-episode psychosis (FEP) clients. We also evaluated whether participation in the platform was related to reduced loneliness, improved social integration and increased psychological well-being.
METHODS: Twenty-six participants diagnosed with a schizophrenia spectrum disorder were provided access to the moderated Horyzons platform for 12 weeks. During the intervention period, participants were encouraged to access therapeutic content and social components embedded within the site. Participants were recruited from three first-episode coordinated specialty care clinics in North Carolina and assessed at four time points: baseline, mid-treatment, post-treatment and 1-month follow-up.
RESULTS: Findings indicated that Horyzons was both feasible and very well tolerated, with a 92.3% retention rate and 79.2% of participants actively engaged in the platform. The most commonly identified personal strengths selected by Horyzons users were creativity (61.5%), curiosity (42.3%) and courage (38.5%). Feedback from participants indicated Horyzons could be improved by the development of a smartphone application, expanding the size of the Horyzons community and facilitating private messages between users. Preliminary results with engaged participants showed the greatest improvements in psychosis-related symptoms, followed by self-reported experience of negative emotions, depressive symptoms and loneliness.
CONCLUSIONS: This open trial found that Horyzons is both feasible and acceptable to FEP persons early in the course of illness living in the United States.
© 2020 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  early intervention; first-episode psychosis; loneliness; social integration; social media

Mesh:

Year:  2020        PMID: 32067415     DOI: 10.1111/eip.12947

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  6 in total

Review 1.  Digital interventions for subjective and objective social isolation among individuals with mental health conditions: a scoping review.

Authors:  Gigi Toh; Eiluned Pearce; John Vines; Sarah Ikhtabi; Mary Birken; Alexandra Pitman; Sonia Johnson
Journal:  BMC Psychiatry       Date:  2022-05-12       Impact factor: 4.144

2.  Efficiency of an Online Health-Promotion Program in Individuals with At-Risk Mental State during the COVID-19 Pandemic.

Authors:  Ching-Lun Tsai; Cheng-Hao Tu; Jui-Cheng Chen; Hsien-Yuan Lane; Wei-Fen Ma
Journal:  Int J Environ Res Public Health       Date:  2021-11-12       Impact factor: 3.390

Review 3.  Social media and schizophrenia: An update on clinical applications.

Authors:  Lakshan N Fonseka; Benjamin K P Woo
Journal:  World J Psychiatry       Date:  2022-07-19

4.  A novel smartphone-based intervention targeting sleep difficulties in individuals experiencing psychosis: A feasibility and acceptability evaluation.

Authors:  Kathryn M Taylor; Jonathan Bradley; Matteo Cella
Journal:  Psychol Psychother       Date:  2022-04-28       Impact factor: 3.966

5.  Social media-based interventions for adolescent and young adult mental health: A scoping review.

Authors:  Kaylee Payne Kruzan; Kofoworola D A Williams; Jonah Meyerhoff; Dong Whi Yoo; Linda C O'Dwyer; Munmun De Choudhury; David C Mohr
Journal:  Internet Interv       Date:  2022-09-28

6.  A Digital Health Innovation to Prevent Relapse and Support Recovery in Youth Receiving Specialized Services for First-Episode Psychosis: Protocol for a Pilot Pre-Post, Mixed Methods Study of Horyzons-Canada (Phase 2).

Authors:  Shalini Lal; John F Gleeson; Simon D'Alfonso; Geraldine Etienne; Ridha Joober; Martin Lepage; Hajin Lee; Mario Alvarez-Jimenez
Journal:  JMIR Res Protoc       Date:  2021-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.